onepharm Nominates Oliver Szolar as Chief Scientific Officer
7/18/2007 12:15:13 PM
Vienna – 18th July 2007 -- Dr Oliver Szolar is the new Chief Scientific Officer (CSO) of onepharm, a Viennese biotech company specialised in the development of new antiviral drugs. Since the company’s foundation in 2005, Oliver Szolar has been responsible for analytical sciences, screening and scientific affairs. Oliver Szolar took over the position of CSO, which was newly created against the background of onepharm’s continuously increasing operations, with effect of beginning of July.
comments powered by